Latest CDI Stories

Atlanta managed IT services live Internet radio show to highlight innovative concepts that make businesses successful. Atlanta, GA (PRWEB) May 28, 2013 Computer Design and Integration’s (CDI) managed IT services division today announced the launch of "Silver Lining in the Cloud," a weekly radio show that will highlight and promote leading businesses and business leaders in the Southeast. Co-hosted by seasoned sales and marketing executives Nikole Smith-Toptas and Dominick...

Company releases industry's first fully-integrated CAC and CDI solution at ACDIS. NASHVILLE, Tenn., May 21, 2013 /PRNewswire/ -- BayScribe, a leading clinical documentation technology company, today announced a new cloud-based offering aimed at eliminating bottlenecks in the documentation and coding process. The new application, v6 CACDIS, creates structured data from unstructured text, thereby facilitating fluid communication between clinical documentation improvement specialists...

Certain types of anti-depressants have been linked to an increase in the risk of Clostridium difficile infection (CDI) finds a study in BioMed Central's open access journal BMC Medicine. Awareness of this link should improve identification and early treatment of CDI. CDI is one of the most common hospital acquired infections and is responsible for more than 7000 deaths annually in the USA alone. Several types of medications are thought to increase risk of CDI, including anti-depressants,...

Growing Competition Among Highly Effective Therapies Will Likely Constrain Uptake of Emerging Therapies, According to a New Report from Decision Resources BURLINGTON, Mass., April 30, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European infectious disease specialists agree that effect on recurrence rate is one of the drug attributes that most influences their...

Specialised Therapeutics Australia to Launch DIFICID May 14, 2013 JERSEY CITY, N.J., April 26, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Therapeutic Goods Administration, the Australian regulatory body for therapeutic goods such as medicines, has approved DIFICID® (fidaxomicin) tablets for the treatment of confirmed Clostridium difficile infection (CDI) in adults. DIFICID will be available to patients in Australia starting May 14,...

EXTON, Pa., April 22, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM), an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections (CDI). CDI is a common and dangerous gastrointestinal...

CHERTSEY, England, April 19, 2013 /PRNewswire/ -- Clostridiumdifficile infection (CDI), a potentially fatal disease, is one of the most common healthcare-associated infections[1] Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.[2] In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts...

TORONTO, April 10, 2013 /CNW/ - Alacer Gold Corp. ("Alacer") [TSX: ASR and ASX: AQG] announced today that its Board of Directors has declared a special cash dividend of US$0.24 per share (approximately US$70 million) payable on April 30, 2013 (Toronto time) to shareholders of record at the close of business on April 19, 2013 in connection with the sale of Alacer's 49% interest in the Frog's Leg Mine. The dividend payment applies to holders of Alacer's common shares, which trade...

Perth software development firm Anahata Technologies Pty Ltd announces it will be defaulting to JBoss Weld as CDI Implementation. Perth, WA (PRWEB) January 15, 2013 Perth Software Development company Anahata Technologies Pty Ltd announces it will be defaulting to JBoss Weld as CDI Implementation. Weld - JSR-299 Reference Implementation of CDI is the new Java standard for dependency injection and contextual lifecycle management led by Gavin King for Red Hat, Inc. and is a Java Community...

ROCKVILLE, Md., Dec. 3, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today that the Company closed the previously announced deal with Prev AbR LLC (Prev) and acquired a series of beta-lactamase compounds (P1A, P2A and P3A) and related assets targeting the prevention of Clostridium difficile (C. diff) infection. Utilizing the newly acquired biologic compounds,...